Related Experiment Videos

Effect of methylglyoxal on rat liver lysosome-vacuolar apparatus

Research Communications in Chemical Pathology and Pharmacology
|July 1, 1981
PubMed

Insights

Methylglyoxal (MeG) administration to rats increased lysosome osmotic fragility and decreased acid phosphatase activity. Cycloheximide (CHM) prevented these effects, indicating MeG stimulates liver autophagy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Toxicology

Background:

  • Methylglyoxal (MeG) is a reactive dicarbonyl compound implicated in diabetic complications.
  • Lysosomes are key organelles involved in cellular degradation and recycling.
  • Autophagy is a crucial cellular process for maintaining homeostasis.

Purpose of the Study:

  • To investigate the effects of methylglyoxal (MeG) administration on rat liver lysosome integrity and function.
  • To explore the potential role of protein synthesis in MeG-induced cellular changes.
  • To determine if MeG stimulates autophagy in rat liver cells.

Main Methods:

  • Rats were administered methylglyoxal (MeG).
  • Lysosome integrity and osmotic fragility were assessed.
  • Residual latent activity (RLA) of acid phosphatase was measured.
  • The effect of cycloheximide (CHM) pretreatment on MeG-induced changes was evaluated.

Main Results:

  • MeG administration did not alter liver lysosome integrity.
  • Lysosome osmotic fragility significantly increased post-MeG treatment.
  • A significant decrease in residual latent activity (RLA) of acid phosphatase was observed.
  • Cycloheximide (CHM) pretreatment prevented the changes in RLA and osmotic fragility.

Conclusions:

  • Methylglyoxal (MeG) induces significant changes in lysosome osmotic fragility and acid phosphatase activity in rat liver.
  • These MeG-induced effects are dependent on protein synthesis.
  • The findings strongly suggest that MeG stimulates autophagy in the rat liver.

Related Concept Videos